Diagnosis of Musculoskeletal Tumors and Tumor-like Conditions

lt;p>Piero Picci, MD, has spent his entire career at the Rizzoli Orthopaedic Institute in Bologna, first as a pathologist and then as an oncologist. He became Director of the Laboratory of Oncologic Research in 1995 and Vice-Director of the Department of Musculoskeletal Oncology in 1999. He was Vice Scientific Director of the institute from 1999 to 2002 and Scientific Director from 2004 to 2007. From 1982 to 1994 he was also a contract professor at the Postgraduate School in Oncology and Orthopaedics at the University of Bologna. Dr. Picci is the author of 500 publications on MEDLINE and has an h-index of 90. He has been President of the Italian Sarcoma Group and the European Musculoskeletal Oncology Society. He is an associate editor and reviewer for several journals and a project reviewer for international organizations.

Marco Manfrini, MD, was born April 30^th, 1955. He obtained the Board of Orthopaedics at the University of Bologna in 1985 where he was trained by Prof. M. Campanacci, than he had a Reserch Fellowship in Orthopedic Oncology at the University of Florida , Gainesville (USA) in 1986-1987 with Prof W.F. Enneking. Since 1988 he has been promoting at the Istituto Rizzoli, the annual international Course on Musculo-Skeletal Pathology. He is actually in charge of the Specialist Referral Center "Innovative techniques in surgical treatment of musculoskeletal tumors of pediatric age"aggregated to the III Clinic of Orthopaedic Oncology at Istituto Ortopedico Rizzoli. He is author of more  than 100 publications on international indexed journals  and  lecturer in more than 100 International Congresses. From the beginning of his career he dedicated to the original applications of biological techniques for reconstructive surgery in  Musculoskeletal Oncology,  especially in children and young adults.

Davide Maria Donati, MD, since 2012 has been Associate Professor of The Department of Biomedical and Neuromotor Sciences at Alma Mater Studiorum-Univeristy of Bologna and since 2016 serves as the Director of The III Clinic prevalently oncologic at Rizzoli Orthopaedic Institute in Bologna. His primary research and clinical interests relate to oncological surgery of bones and soft tissues, rare musculoskeletal diseases, regenerative medicine (osteonecrosis, cartilage defects, consolidation delay) and bone infections. He is the principle investigator and co-chair in numerous clinical trials within the Rizzoli Institute as well as in various research projects outside the Rizzoli Institute. He is author to more than 300 manuscripts including conference proceedings and journal articles in the fields of Biochemistry, Genetics and Molecular Biology- Medicine- Materials Science- Immunology and Microbiology- Engineering- Oncological Surgery.

Marco Gambarotti, MD, has been a pathologist at the Rizzoli Orthopaedic Institute in Bologna since May 2008. He has diagnosed more than 45,000 cases of bone and soft tissue pathology. Dr. Gambarotti is author or co-author of more than 80 scientific papers in national or international journals (h-index: 19). He is a member of SIAPEC - IAP (Italian division of the International Academy of Pathology), the Italian Sarcoma Group, the International Skeletal Society, the European Musculoskeletal Oncology Society, and AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica). He is involved in the organization and management of the Rizzoli Orthopedic Institute's biobank in the National Network of Biobanks.

Alberto Righi, MD, PhD, is a pathologist in the Pathology Department of the Rizzoli Orthopaedic Institute in Bologna, where he is among those responsible for the molecular diagnostics of bone and soft tissue sarcoma and for organization and management of the institute's biobank in the National Network of Biobanks. Dr. Righi's scientific activi

PART I INTRODUCTION Chapter 1 Epidemiology of Bone Lesions.- Chapter 2 Classification of Primary Bone Lesions.- Chapter 3 General Principles of Bone Pathology.- Chapter 4 Epidemiology of Soft Tissue Lesions.- Chapter 5 Classification of Soft Tissue Lesions.- Chapter 6 General Principle of Soft Tissue Pathology and Molecular Alterations in Musculoskeletal Lesions.- Chapter 7 General Principles of Imaging.- Chapter 8 Staging.- PART II PSEUDOTUMORAL AND BENIGN LESIONS OF BONE Chapter 9 Simple Bone Cyst (Unicameral Bone Cyst).- Chapter 10 Langerhans Cell Histiocytosis.- Chapter 11 Histiocytic Fibroma.- Chapter 12 Fibrous Dysplasia.- Chapter 13 Osteofibrous Dysplasia of Long Bones.- Chapter 14 Desmoid Fibroma (Desmoplastic Fibroma of Bone).- Chapter 15 Chondromas.- Chapter 16 Osteochondromas.- Chapter 17 Chondroblastoma.- Chapter 18 Chondromyxoid Fibroma.- Chapter 19 Osteoid Osteoma.- Chapter20 Osteoblastoma.- Chapter 21 Aneurysmal Bone Cyst (ABC).- Chapter 22 Giant Cell Tumor.- Chapter 23 Biology of Giant Cell Tumor.- Chapter 24 Other Rare Pseudotumoral Lesions:.- Chapter 25 Other Rare Benign Lesions.- PART III BENIGN LESIONS OF SOFT TISSUES Chapter 26 Myositis Ossificans.- Chapter 27 Pigmented Villonodular Synovitis and Giant Cell Tumor of the Tendon Sheaths (Tenosynovial Giant Cell Tumor).- Chapter 28 Synovial Chondromatosis.- Chapter 29 Fibromatosis (All Types).- Chapter 30 Lipomas.- Chapter 31 Neurofibroma.- Chapter 32 Schwannoma.- Chapter 33 Other Rare Conditions of Pseudotumoral and Benign Lesions of Soft Tissues.- PART IV PRIMARY MALIGNANT TUMORS Chapter 34 Chondrosarcomas (CHS).- Chapter 35 Biology of Conventional Chondrosarcoma.- Chapter 36 Osteosarcomas (OS).- Chapter 37 Biology of Osteosarcomas.- Chapter 38 Chemotherapy of Osteosarcoma.- Chapter 39 Small Blue Round Cell Tumors.- Chapter 40 Biology of Ewing Sarcoma.- Chapter 41 Chemotherapy of Ewing Sarcoma.- Chapter 42 Fibroblastic/Myofibroblastic Tumors.- Chapter 43 Nerve Sheath Tumor.- Chapter 44 Smooth and Striated Muscle.- Chapter 45 Sarcomas with Uncertain Differentiation.- Chapter 46 Vascular Tumors.- Chapter 47 Liposarcomas.- Chapter 48 Chemotherapy of Soft Tissue Sarcomas.- Chapter 49 Adamantinoma.- Chapter 50 Notochordol Differentiation.- Chapter 51 Other Rare Malignant Lesions.- PART V SYSTEMIC LESIONS Chapter 52 Primary Lymphoma of Bone.- Chapter 53 Multiple Myeloma.- Chapter 54 Hodgkin's Disease in Bone.- Chapter 55 Metastatic Lesions.